Viewing Study NCT01363193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-02-07 @ 4:36 AM
Study NCT ID: NCT01363193
Status: UNKNOWN
Last Update Posted: 2013-05-14
First Post: 2011-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
Sponsor: Nazareth Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
None Morbid Obesity View
None Venous Thromboembolism View
None Atrial Fibrillation View
None Angina View
None Chest Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Weight-based heparin dosing View
None Obesity View
None Body Mass Index View
None Venous thromboembolism View
None Atrial fibrillation View
None Lean body weight View
None Unfractionated heparin View
None heparin View